NFE2 and cancer: In contrast, H3.1K27M DIPG displayed an enrichment of motifs related to Nuclear Factor Erythroid 2 (NFE2) signaling, particularly involving NFE2L3, which is recognized for its involvement in mediating cancer cell resistance to therapy [35].